<

 
Data updated 2025-05-07 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date12783804.3 (espacenet)  (Federated)  (European Patent Register), 20121031
Patent/reg. no. and dateDK/EP 2780011, 20180411
Publication date20140924
Priority no. and dateUS 201161558582 P, 20111111
EP pub. no. and date EP 2780011 20140924
Effective date
Applicant/ownerEli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.P81801331DK00E
InventorCHAN, Edward, Michael, Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
PRATT, Susan, Elizabeth, Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
STANCATO, Louis, Frank, Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/282 (2006.01) , A61K 31/437 (2006.01) , A61K 31/555 (2006.01) , A61K 31/7068 (2006.01) , A61K 33/24 (2006.01) , A61P 35/00 (2006.01) 
TitleKOMBINATIONSTERAPI MOD OVARIECANCER
Int. application no.US2012062634
Int. publication no.WO2013070460
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact